Back to the future: How biology and technology could change the role of ptfe grafts in vascular access management

Seminars in Dialysis

Volumn 25, Issue 5, 2012, Pages 495-504

  Roy Chaudhury, Prabir ^a,b   El Khatib, Mahmoud ^b   Campos Naciff, Begona ^b   Wadehra, Davinder ^b   Ramani, Karthik ^b   Leesar, Massoud ^b   Mistry, Meenakshi ^b   Wang, Yang ^b   Chan, Jenq Shyong ^b,c   Lee, Timmy ^a,b   Munda, Rino ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c TAO YUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

POLITEF;

ARTERIOVENOUS SHUNT; ARTICLE; BLOOD VESSEL PROSTHESIS; CHRONIC KIDNEY FAILURE; GRAFT OCCLUSION; HUMAN; INDWELLING CATHETER; PROSTHESIS FAILURE; RENAL REPLACEMENT THERAPY; THROMBOSIS;

ARTERIOVENOUS SHUNT, SURGICAL; BLOOD VESSEL PROSTHESIS; CATHETERS, INDWELLING; GRAFT OCCLUSION, VASCULAR; HUMANS; KIDNEY FAILURE, CHRONIC; POLYTETRAFLUOROETHYLENE; PROSTHESIS FAILURE; RENAL DIALYSIS; THROMBOSIS;

EID: 84866532600     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2012.01091.x     Document Type: Article

References (99)

1. Lee T, Roy-Chaudhury P: Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv Chronic Kidney Dis 16:329-338, 2009
2. Roy-Chaudhury P, Lee T: Vascular stenosis: biology and interventions. Curr Opin Nephrol Hypertens 16:516-522, 2007
3. Roy-Chaudhury P, Kelly BS, Melhem M, Zhang J, Li J, Desai P, Munda R, Heffelfinger SC: Vascular access in hemodialysis: issues, management, and emerging concepts. Cardiol Clin 23:249-273, 2005
4. Roy-Chaudhury P, Spergel LM, Besarab A, Asif A, Ravani P: Biology of arteriovenous fistula failure. J Nephrol 20:150-163, 2007
5. Roy-Chaudhury P, Sukhatme VP, Cheung AK: Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol 17:1112-1127, 2006
6. Hakim RM, Himmelfarb J: Hemodialysis access failure: a call to action-revisited. Kidney Int 76:1040-1048, 2009
7. Allon M: Current management of vascular access. Clin J Am Soc Nephrol 2:786-800, 2007
8. Patel ST, Hughes J, Mills JL Sr: Failure of arteriovenous fistula maturation: an unintended consequence of exceeding dialysis outcome quality Initiative guidelines for hemodialysis access. J Vasc Surg 38:439-445, 2003, discussion 45
9. Lok CE: Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol 2:1043-1053, 2007
10. Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, Himmelfarb J, Vazquez MA, Gassman JJ, Greene T, Radeva MK, Braden GL, Ikizler TA, Rocco MV, Davidson IJ, Kaufman JS, Meyers CM, Kusek JW, Feldman HI; Dialysis Access Consortium Study Group: Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 299:2164-2171, 2008
11. Silva MB Jr, Hobson RW II, Pappas PJ, Jamil Z, Araki CT, Goldberg MC, Gwertzman G, Padberg FT Jr: A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg 27:302-307, 1998; discussion 7-8
12. Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D: risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol 17:3204-3212, 2006
13. Falk A: Maintenance and salvage of arteriovenous fistulas. J Vasc Interv Radiol 17:807-813, 2006
14. Nasser GNB, Rhee E, Achkar K: Endovascular treatment of the "failing to mature" arteriovenous fistula. Clin J Am Soc Nephrol 1:275-280, 2006
15. Lee T, Ullah A, Allon M, Succop P, El-Khatib M, Munda R, Roy-Chaudhury P: Decreased cumulative access survival in arteriovenous fistulas requiring interventions to promote maturation. Clin J Am Soc Nephrol 6:575-581, 2010
16. Roy-Chaudhury P, Kelly BS, Melhem M, Zhang J, Li J, Desai P, Munda R, Heffelfinger SC: Novel therapies for hemodialysis vascular access dysfunction: fact or fiction! Blood Purif 23:29-35, 2005
17. Dixon BS, Beck GJ, Vazquez MA, Greenberg A, Delmez JA, Allon M, Dember LM, Himmelfarb J, Gassman JJ, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Fenves AZ, Kaufman JS, Cotton JR Jr, Martin KJ, McNeil JW, Rahman A, Lawson JH, Whiting JF, Hu B, Meyers CM, Kusek JW, Feldman HI; DAC Study Group: Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med 360:2191-2201, 2009
18. Schwab SJ, Harrington JT, Singh A, Roher R, Shohaib SA, Perrone RD, Meyer K, Beasley D: Vascular access for hemodialysis [clinical conference]. Kidney Int 55:2078-2090, 1999
19. Hodges TC, Fillinger MF, Zwolak RM, Walsh DB, Bech F, Cronenwett JL: Longitudinal comparison of dialysis access methods: risk factors for failure. J Vasc Surg 26:1009-1019, 1997
20. USRDS: USRDS 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008.
21. Allon M, Daugirdas J, Depner TA, Greene T, Ornt D, Schwab SJ: Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis 47:469-477, 2006
22. Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, Rayner HC, Saito A, Sands JJ, Saran R, Gillespie B, Wolfe RA, Port FK: Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis 53:475-491, 2009
23. Perl J, Wald R, McFarlane P, Bargman JM, Vonesh E, Na Y, Jassal SV, Moist L: Hemodialysis vascular access modifies the association between dialysis modality and survival. J Am Soc Nephrol 22:1113-1121, 2011
24. Allon M, Lok CE: Dialysis fistula or graft: the role for randomized clinical trials. Clin J Am Soc Nephrol 5:2348-2354, 2010
25. Roy-Chaudhury P, Kelly BS, Miller MA, Reaves A, Armstrong J, Nanayakkara N, Heffelfinger SC: Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 59:2325-2334, 2001
26. Roy-Chaudhury P, Wang Y, Krishnamoorthy M, Zhang J, Banerjee R, Munda R, Heffelfinger S, Arend L: Cellular phenotypes in human stenotic lesions from haemodialysis vascular access. Nephrol Dial Transplant 24:2786-2791, 2009
27. Sottiurai VS, Yao JS, Flinn WR, Batson RC: Intimal hyperplasia and neointima: an ultrastructural analysis of thrombosed grafts in humans. Surgery 93:809-817, 1983
28. Rekhter M, Nicholls S, Ferguson M, Gordon D: Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb 13:609-617, 1993
29. Stracke S, Konner K, Kostlin I, Friedl R, Jehle PM, Hombach V, Keller F, Waltenberger J: Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas. Kidney Int 61:1011-1019, 2002
30. Weiss MF, Scivittaro V, Anderson JM: Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. Am J Kidney Dis 37:970-980, 2001
31. Kelly BS, Heffelfinger SC, Whiting JF, Miller MA, Reaves A, Armstrong J, Narayana A, Roy-Chaudhury P: Aggressive venous neointimal hyperplasia in a pig model of arteriovenous graft stenosis. Kidney Int 62:2272-2280, 2002
32. Li L, Terry CM, Blumenthal DK, Kuji T, Masaki T, Kwan BC, Zhuplatov I, Leypoldt JK, Cheung AK: Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model. Nephrol Dial Transplant 22:3139-3146, 2007
33. Li L, Terry CM, Shiu YT, Cheung AK: Neointimal hyperplasia associated with synthetic hemodialysis grafts. Kidney Int 74:1247-1261, 2008
34. Misra S, Doherty MG, Woodrum D, Homburger J, Mandrekar JN, Elkouri S, Sabater EA, Bjarnason H, Fu AA, Glockner JF, Greene EL, Mukhopadhyay D: Adventitial remodeling with increased matrix metalloproteinase-2 activity in a porcine arteriovenous polytetrafluoroethylene grafts. Kidney Int 68:2890-2900, 2005
35. Mattsson EJ, Kohler TR, Vergel SM, Clowes AW: Increased blood flow induces regression of intimal hyperplasia. Arterioscler Thromb Vasc Biol 17:2245-2249, 1997
36. Loth F, Fischer PF, Arslan N, Bertram CD, Lee SE, Royston TJ, Shaalan WE, Bassiouny HS: Transitional flow at the venous anastomosis of an arteriovenous graft: potential activation of the ERK1/2 mechanotransduction pathway. J Biomech Eng 125:49-61, 2003
37. Fillinger MF, Kerns DB, Bruch D, Reinitz ER, Schwartz RA: Does the end-to-end venous anastomosis offer a functional advantage over the end-to-side venous anastomosis in high-output arteriovenous grafts? J Vasc Surg 12:676-688, 1990; discussion 88-90
38. Fillinger MF, Reinitz ER, Schwartz RA, Resetarits DE, Paskanik AM, Bruch D, Bredenberg CE: Graft geometry and venous intimal-medial hyperplasia in arteriovenous loop grafts. J Vasc Surg 11:556-566, 1990
39. Sivanesan S, How TV, Bakran A: Characterizing flow distributions in AV fistulae for haemodialysis access. Nephrol Dial Transplant 13:3108-3110, 1998
40. Sivanesan S, How TV, Black RA, Bakran A: Flow patterns in the radiocephalic arteriovenous fistula: an in vitro study. J Biomech 32:915-925, 1999
41. Longest PW, Kleinstreuer C, Andreotti PJ: Computational analyses and design improvements of graft-to-vein anastomoses. Crit Rev Biomed Eng 28:141-147, 2000
42. Remuzzi A, Ene-Iordache B, Mosconi L, Bruno S, Anghileri A, Antiga L, Remuzzi G: Radial artery wall shear stress evaluation in patients with arteriovenous fistula for hemodialysis access. Biorheology 40:423-430, 2003
43. Ene-Iordache B, Mosconi L, Antiga L, Bruno S, Anghileri A, Remuzzi G, Remuzzi A: Radial artery remodeling in response to shear stress increase within arteriovenous fistula for hemodialysis access. Endothelium 10:95-102, 2003
44. Van Tricht I, De Wachter D, Tordoir J, Verdonck P: Hemodynamics and complications encountered with arteriovenous fistulas and grafts as vascular access for hemodialysis: a review. Ann Biomed Eng 33:1142-1157, 2005
45. Longest PW, Kleinstreuer C, Deanda A: Numerical simulation of wall shear stress and particle-based hemodynamic parameters in pre-cuffed and streamlined end-to-side anastomoses. Ann Biomed Eng 33:1752-1766, 2005
46. Misra S, Woodrum DA, Homburger J, Elkouri S, Mandrekar JN, Barocas V, Glockner JF, Rajan DK, Mukhopadhyay D: Assessment of wall shear stress changes in arteries and veins of arteriovenous polytetrafluoroethylene grafts using magnetic resonance imaging. Cardiovasc Intervent Radiol 29:624-629, 2006
47. Unnikrishnan S, Huynh TN, Brott BC, Ito Y, Cheng CH, Shih AM, Allon M, Anayiotos AS: Turbulent flow evaluation of the venous needle during hemodialysis. J Biomech Eng 127:1141-1146, 2005
48. Huynh TN, Chacko BK, Teng X, Brott BC, Allon M, Kelpke SS, Thompson JA, Patel RP, Anayiotos AS: Effects of venous needle turbulence during ex vivo hemodialysis on endothelial morphology and nitric oxide formation. J Biomech 40(10):2158-2166, 2007
49. Chang CJ, Ko PJ, Hsu LA, Ko YS, Ko YL, Chen CF, Huang CC, Hsu TS, Lee YS, Pang JH: Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis. Am J Kidney Dis 43:74-84, 2004
50. Misra S, Fu AA, Rajan DK, Juncos LA, McKusick MA, Bjarnason H, Mukhopadhyay D: Expression of hypoxia inducible factor-1 alpha, macrophage migration inhibition factor, matrix metalloproteinase-2 and -9, and their inhibitors in hemodialysis grafts and arteriovenous fistulas. J Vasc Interv Radiol 19:252-259, 2008
51. Misra S, Fu AA, Puggioni A, Karimi KM, Mandrekar JN, Glockner JF, Juncos LA, Anwer B, McGuire AM, Mukhopadhyay D: Increased shear stress with upregulation of VEGF-A and its receptors and MMP-2, MMP-9, and TIMP-1 in venous stenosis of hemodialysis grafts. Am J Physiol Heart Circ Physiol 294:H2219-H2230, 2008
52. Misra S, Fu AA, Anderson JL, Glockner JF, McKusick MA, Bjarnason H, Woodrum DA, Mukhopadhyay D: Fetuin-A expression in early venous stenosis formation in a porcine model of hemodialysis graft failure. J Vasc Interv Radiol 19:1477-1482, 2008
53. Misra S, Fu AA, Puggioni A, Glockner JF, McKusick MA, Bjarnason H, Mukhopadhyay D: Proteomic profiling in early venous stenosis formation in a porcine model of hemodialysis graft. J Vasc Interv Radiol 20:241-251, 2009
54. Lee T, Chauhan V, Krishnamoorthy M, Wang Y, Arend L, Mistry MJ, El-Khatib M, Banerjee R, Munda R, Roy-Chaudhury P: Severe venous neointimal hyperplasia prior to dialysis access surgery. Nephrol Dial Transplant 26:2264-2270, 2011
55. Wasse H, Huang R, Naqvi N, Smith E, Wang D, Husain A: Inflammation, oxidation and venous neointimal hyperplasia precede vascular injury from AVF creation in CKD patients. J Vasc Access 13:168-174, 2012
56. Kaufman JS, O'Connor TZ, Zhang JH, Cronin RE, Fiore LD, Ganz MB, Goldfarb DS, Peduzzi PN; Veterans Affairs Cooperative Study Group on Hemodialysis Access Graft Thrombosis: Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol 14:2313-2321, 2003
57. Crowther MA, Clase CM, Margetts PJ, Julian J, Lambert K, Sneath D, Nagai R, Wilson S, Ingram AJ: Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial. J Am Soc Nephrol 13:2331-2337, 2002
58. Dixon BS, Beck GJ, Dember LM, Vazquez MA, Greenberg A, Delmez JA, Allon M, Himmelfarb J, Hu B, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Lawson JH, Cotton JR Jr, Kusek JW, Feldman HI; Dialysis Access Consortium (DAC) Study Group: Use of aspirin associates with longer primary patency of hemodialysis grafts. J Am Soc Nephrol 22:773-781, 2011
59. Schmitz PG, McCloud LK, Reikes ST, Leonard CL, Gellens ME: Prophylaxis of hemodialysis graft thrombosis with fish oil: double-blind, randomized, prospective trial. J Am Soc Nephrol 13:184-190, 2002
60. Lok CE, Allon M, Donnelly S, Dorval M, Hemmelgarn B, Moist L, Oliver MJ, Tonelli M, Stanley K: Design of the fish oil inhibition of stenosis in hemodialysis grafts (FISH) study. Clin Trials 4:357-367, 2007
61. Lok CE, Moist L, Hemmelgarn BR, Tonelli M, Vazquez MA, Dorval M, Oliver M, Donnelly S, Allon M, Stanley K; Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. JAMA 307:1809-1816, 2012
62. Kohler TR, Toleikis P, Gravett DM, Avelar RL: Inhibition of neointimal hyperplasia in a sheep model of dialysis access failure with the bioabsorbable Vascular Wrap Pacliteaxel Eluting Mesh. J Vasc Surg 45:1029-1038, 2007
63. Kelly B, Melhem M, Zhang J, Kasting G, Li J, Krishnamoorthy M, Heffelfinger S, Rudich S, Desai P, Roy-Chaudhury P: Perivascular paclitaxel wraps block arteriovenous graft stenosis in a pig model. Nephrol Dial Transplant 21:2425-2431, 2006
64. Paulson W, Kipshidze N, Kipiani K, Beridze N, DeVita M, Shenoy S, Iyer S: Safety and efficacy of local periadventitial delivery of sirolimus for improving hemodialysis graft patency: first human experience with a sirolimus-eluting collagen membrane (Coll-R). Nephrol Dial Transplant 27:1219-1224, 2012
65. Nugent HM, Groothuis A, Seifert P, Guerraro JL, Nedelman M, Mohanakumar T, Edelman ER: Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig. J Vasc Res 39:524-533, 2002
66. Nugent HM, Rogers C, Edelman ER: Endothelial implants inhibit intimal hyperplasia after porcine angioplasty. Circ Res 84:384-391, 1999
67. Nugent HM, Sjin RT, White D, Milton LG, Manson RJ, Lawson JH, Edelman ER: Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts. J Vasc Surg 46:548-556, 2007
68. Conte MS, Nugent HM, Gaccione P, Guleria I, Roy-Chaudhury P, Lawson JH: Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study. J Vasc Surg 50:1359.e1-1368.e1, 2009
69. Conte MS, Nugent HM, Gaccione P, Roy-Chaudhury P, Lawson JH: Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling. J Vasc Surg 54:1383-1389, 2011
70. Hiltunen MO, Laitinen M, Turunen MP, Jeltsch M, Hartikainen J, Rissanen T, Laukkanen J, Niemi M, Kossila M, Häkkinen T, Kivelä A, Enholm B, Mansukoski H, Turunen AM, Alitalo K, Ylä-Herttuala S: Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation 102:2262-2268, 2000
71. Dixon B, Peden EK, Leeser DB, El-Khatib MT, Roy-Chaudhury P, Lawson J, Menard M, Glickman MH, Dember LM, Burke SK: Effect of recombinant human type 1 pancreatic elastase (PRT-201) treatment on fistula patency. JASN, 2011; [SA-OR457]
72. Lee BH, Lee JE, Lee KW, Nam HY, Jeon HJ, Sung YJ, Kim JS, Lim HJ, Park JS, Ko JY, Kim DJ: Coating with paclitaxel improves graft survival in a porcine model of haemodialysis graft stenosis. Nephrol Dial Transplant 22:2800-2804, 2007
73. Baek I, Bai CZ, Hwang J, Park J, Park JS, Kim DJ: Suppression of neointimal hyperplasia by sirolimus-eluting expanded polytetrafluoroethylene (ePTFE) haemodialysis grafts in comparison with paclitaxel-coated grafts. Nephrol Dial Transplant 27:1997-2004, 2011
74. Aoki J, Serruys PW, van Beusekom H, Ong AT, McFadden EP, Sianos G, van der Giessen WJ, Regar E, de Feyter PJ, Davis HR, Rowland S, Kutryk MJ: Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol 45:1574-1579, 2005
75. Ong AT, Aoki J, Kutryk MJ, Serruys PW: How to accelerate the endothelialization of stents. Arch Mal Coeur Vaiss 98:123-126, 2005
76. Rotmans JI, Heyligers JM, Verhagen HJ, Velema E, Nagtegaal MM, de Kleijn DP, de Groot FG, Stroes ES, Pasterkamp G: In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation 112:12-18, 2005
77. Roy-Chaudhury P: Endothelial progenitor cells, neointimal hyperplasia, and hemodialysis vascular access dysfunction: novel therapies for a recalcitrant clinical problem. Circulation 112:3-5, 2005
78. Roy-Chaudhury P, Kohler T, Avelar R: Rationale, design, methods and statistical aspects of a randomized, multicenter, clinical study to assess the effectiveness of maintaining patency and the safety of the Vascular Wrap™ Paclitaxel-Eluting Mesh Implanted with a Lifespan® ePTFE Vascular Graft for Hemodialysis Vascular Access. J Am Soc Nephrol 18:469A, 2007
79. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Böhm M, Speck U: Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 355:2113-2124, 2006
80. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwälder U, Beregi JP, Claussen CD, Oldenburg A, Scheller B, Speck U: Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 358:689-699, 2008
81. Katsanos K, Karnabatidis D, Kitrou P, Spiliopoulos S, Christeas N, Siablis D: Drug-coated balloon angioplasty in hemodialysis access. 38th Annual Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium), 2011, New York City, 2011
82. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R; RAVEL Study Group: A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773-1780, 2002
83. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators: A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221-231, 2004
84. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB: Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356:998-1008, 2007
85. Rotmans JI, Pattynama PM, Verhagen HJ, Hino I, Velema E, Pasterkamp G, Stroes ES: Sirolimus-eluting stents to abolish intimal hyperplasia and improve flow in porcine arteriovenous grafts: a 4-week follow-up study. Circulation 111:1537-1542, 2005
86. Tay K, Irani F, Lo R, Taneja M, Teo T, Khoo L, Burgmans M, Yang W, Choong L, Tan S, Chng S, Pasupathy S, Tan B: Prospective randomised controlled trial comparing drug eluting stent (DES) versus percutaneous transluminal angioplasty (PTA) for the treatment of hemodialysis arterio-venous graft (AVG) stenoses: Preliminary report. J Vasc Interv Radiol 22:6S, 2011
87. Haskal ZJ, Trerotola S, Dolmatch B, Schuman E, Altman S, Mietling S, Berman S, McLennan G, Trimmer C, Ross J, Vesely T: Stent graft versus balloon angioplasty for failing dialysis-access grafts. N Engl J Med 62:494-503, 2010
88. Salman L, Asif A: Dialysis: the stent graft for stenosis: let's appraise before we praise. Nat Rev Nephrol 6:503-504, 2010
89. Salman L, Asif A: Stent: graft for nephrologists: concerns and consensus. Clin J Am Soc Nephrol 5:1347-1352, 2010
90. Misra S, Bonan R, Pflederer T, Roy-Chaudhury P, Bravo I, Investigators: A pilot study of vascular brachytherapy in polytetrafluoroethylene dialysis access grafts. Kidney Int 70(11):2006-2013, 2006
91. Roy-Chaudhury P, Arnold P, Seigel J, Misra S. From Basic Biology to Randomized Clinical Trial: The Beta Radiation for ArterioVenous Graft Outflow Stenosis (BRAVO II). Semin Dial. [In Press]
92. Roy-Chaudhury P, Wang Y, Mistry M, Campos B, Lee T, Choe A: "Hybrid" graft reduces venous stenosis in a pig arteriovenous graft model. J Am Soc Nephrol, 2011; FR-PO1978
93. Manson RJ, Ebner A, Gallo S, Chemla E, Mantell M, Deaton D, Roy-Chaudhury P: Arteriovenous fistula creation using the optiflow vascular anastomosis device: A first in man pilot study Semin Dial doi: 10.1111/j.1525-139X.2012.01062.x Epub ahead of print
94. Peck M, Gebhart D, Dusserre N, McAllister TN, L'Heureux N: The evolution of vascular tissue engineering and current state of the art. Cells Tissues Organs 195:144-158, 2011
95. Peck MK, Dusserre N, Zagalski K, Garrido SA, Wystrychowski W, Glickman MH, Chronos NA, Cierpka L, L'Heureux N, McAllister TN: New biological solutions for hemodialysis access. J Vasc Access 12:185-192, 2011
96. L'Heureux N, Dusserre N, Konig G, Victor B, Keire P, Wight TN, Chronos NA, Kyles AE, Gregory CR, Hoyt G, Robbins RC, McAllister TN: Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 12:361-365, 2006
97. McAllister TN, Maruszewski M, Garrido SA, Wystrychowski W, Dusserre N, Marini A, Zagalski K, Fiorillo A, Avila H, Manglano X, Antonelli J, Kocher A, Zembala M, Cierpka L, de la Fuente LM, L'heureux N: Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 373:1440-1446, 2009
98. L'Heureux N, McAllister TN, de la Fuente LM: Tissue-engineered blood vessel for adult arterial revascularization. N Engl J Med 357:1451-1453, 2007
99. Dahl SL, Kypson AP, Lawson JH, Blum JL, Strader JT, Li Y, Manson RJ, Tente WE, DiBernardo L, Hensley MT, Carter R, Williams TP, Prichard HL, Dey MS, Begelman KG, Niklason LE: Readily available tissue-engineered vascular grafts. Sci Transl Med 3:68ra9, 2011